MedTrace Logo

Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device

NCT04031300 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-11-21

No results posted yet for this study

Summary

This pivotal multicenter study has been launched to collect spectral Raman data paired with validated glucose reference values in diabetic patients.

Conditions

Interventions

DEVICE

Prototype 0.5

Investigational Medical Device collecting spectral Raman data non-invasively from tissue

Sponsors & Collaborators

  • RSP Systems A/S

    lead INDUSTRY

Principal Investigators

  • Kirsten Nørgaard, MD · Steno Diabetes Center Copenhagen

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2019-06-01
Completion
2019-06-01

Countries

  • Denmark
  • Germany
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04031300 on ClinicalTrials.gov